The FDA approved Bkemv (eculizumab-aeeb) as the first biosimilar to Soliris (eculizumab) for 2 rare diseases. It was also ...

A literature review revealed new data demonstrating that biosimilar-to-biosimilar switching is safe and effective.

Alvotech and Teva have launched Simlandi in the US; Xbrane Biopharma and STADA Arzneimitel partner with Valorum Biologics to ...

Lakesha Farmer from Cencora discusses innovative pricing and reimbursement models incentivizing biosimilar adoption and ...

Number 3: The FDA approved the first 2 biosimilars referencing Eylea (aflibercept)—Yesafili (aflibercept-jbvf) and Opuviz (aflibercept-yszy)—for the treatment of ophthalmic conditions.